Compare AVAV & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVAV | ALGN |
|---|---|---|
| Founded | 1971 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.5B |
| IPO Year | 2006 | 2000 |
| Metric | AVAV | ALGN |
|---|---|---|
| Price | $123.75 | $154.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 16 |
| Target Price | ★ $213.07 | $190.21 |
| AVG Volume (30 Days) | ★ 1.3M | 843.7K |
| Earning Date | 12-08-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.53 |
| EPS | N/A | ★ 3.09 |
| Revenue | N/A | ★ $387,126,000.00 |
| Revenue This Year | $11.44 | $2.84 |
| Revenue Next Year | $15.34 | $3.49 |
| P/E Ratio | ★ N/A | $49.95 |
| Revenue Growth | N/A | ★ 23.95 |
| 52 Week Low | $113.15 | $130.23 |
| 52 Week High | $408.25 | $200.44 |
| Indicator | AVAV | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 36.90 | 59.62 |
| Support Level | N/A | $153.21 |
| Resistance Level | $165.15 | $162.92 |
| Average True Range (ATR) | 6.37 | 3.74 |
| MACD | -0.66 | 1.92 |
| Stochastic Oscillator | 32.64 | 90.33 |
AeroVironment Inc is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploys autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. The company operates business in two reportable segments: Autonomous Systems (AxS) and Space, Cyber and Directed Energy (SCDE). It derives majority of revenue from Autonomous Systems segment focuses on the design, development, production, delivery, and support of intelligent, multi-domain robotic systems, including UAS, uncrewed underwater vehicles and ground robot systems. Geographically it derives the majority of revenue from domestic operations.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.